LCC in Cantonese: Novel Treatment for Advanced EGFR-mutant NSCLC

Episode
307
Soundcloud
Share

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Rina Hui and Dr. Zhang Li. This episode is part of our Virtual Tumor Board series and will focus on managing EGFR-mutant NSCLC. 

Guest
Molly Li
Molly Li

MD

Clinical Assistant Professor
Department of Clinical Oncology, CUHK, Hong Kong
Rina Hui
Rina Hui

MBBS, PhD, FRACP

Director, Centre of Cancer Medicine
HKU Med
Clinical Professor, University of Hong Kong
Adjunct Professor, University of Sydney
Zhang Li
Zhang Li

MD

Professor, Medical Oncology Department Deputy Director
Lung Cancer Research Center Sun Yat-Sen University